cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
cbdMD (NYSE American: YCBD) has scheduled a conference call on Wednesday, December 18, 2024, at 4:20 p.m. Eastern Time to discuss their fourth quarter and fiscal year 2024 financial results ending September 30, 2024. The company will provide updates on financial performance and business progress. Participants can join via USA/Canada (844-763-8274) or International (647-484-8814) lines. A replay will be available through January 18, 2026, accessible via USA/Canada (855-669-9658) or International (412-317-0088) numbers using passcode 5369354.
cbdMD (NYSE American: YCBD) ha programmato una conferenza telefonica per mercoledì 18 dicembre 2024, alle 16:20 ora orientale per discutere i risultati finanziari del quarto trimestre e dell'anno fiscale 2024 che termina il 30 settembre 2024. L'azienda fornirà aggiornamenti sulle performance finanziarie e sui progressi aziendali. I partecipanti possono unirsi tramite linee USA/Canada (844-763-8274) o Internazionali (647-484-8814). Una registrazione sarà disponibile fino al 18 gennaio 2026, accessibile tramite numeri USA/Canada (855-669-9658) o Internazionali (412-317-0088) utilizzando il codice di accesso 5369354.
cbdMD (NYSE American: YCBD) ha programado una conferencia telefónica para el miércoles 18 de diciembre de 2024, a las 4:20 p.m. hora del este para discutir los resultados financieros del cuarto trimestre y del año fiscal 2024 que finaliza el 30 de septiembre de 2024. La compañía proporcionará actualizaciones sobre el rendimiento financiero y el progreso del negocio. Los participantes pueden unirse a través de líneas de EE. UU./Canadá (844-763-8274) o internacionales (647-484-8814). Una repetición estará disponible hasta el 18 de enero de 2026, accesible a través de números de EE. UU./Canadá (855-669-9658) o internacionales (412-317-0088) utilizando el código de acceso 5369354.
cbdMD (NYSE American: YCBD)는 2024년 12월 18일 수요일, 동부 표준시 오후 4시 20분에 2024 회계연도 4분기 및 2024년 9월 30일 기준 재무 결과를 논의하기 위한 전화 회의를 예정하고 있습니다. 회사는 재무 성과와 비즈니스 진행 상황에 대한 업데이트를 제공합니다. 참가자들은 미국/캐나다(844-763-8274) 또는 국제(647-484-8814) 전화로 참여할 수 있습니다. 녹음은 2026년 1월 18일까지 이용 가능하며, 미국/캐나다(855-669-9658) 또는 국제(412-317-0088) 번호를 사용하여 접근할 수 있고, 비밀번호는 5369354입니다.
cbdMD (NYSE American: YCBD) a programmé un appel conférence pour le mercredi 18 décembre 2024 à 16h20, heure de l'Est afin de discuter des résultats financiers du quatrième trimestre et de l'exercice fiscal 2024 se terminant le 30 septembre 2024. L'entreprise fournira des mises à jour sur la performance financière et l'avancement des affaires. Les participants peuvent se joindre via les lignes USA/Canada (844-763-8274) ou internationales (647-484-8814). Un enregistrement sera disponible jusqu'au 18 janvier 2026, accessible via les numéros USA/Canada (855-669-9658) ou internationaux (412-317-0088) en utilisant le code d'accès 5369354.
cbdMD (NYSE American: YCBD) hat eine Telefonkonferenz für Mittwoch, den 18. Dezember 2024, um 16:20 Uhr Eastern Time angesetzt, um die finanziellen Ergebnisse des vierten Quartals und des Geschäftsjahres 2024, das am 30. September 2024 endet, zu besprechen. Das Unternehmen wird Updates zur finanziellen Leistung und zum Fortschritt des Geschäfts geben. Teilnehmer können über die USA/Kanada (844-763-8274) oder internationale (647-484-8814) Leitungen teilnehmen. Eine Wiederholung wird bis zum 18. Januar 2026 verfügbar sein, erreichbar über USA/Kanada (855-669-9658) oder internationale (412-317-0088) Nummern mit dem Zugangscode 5369354.
- None.
- None.
Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
CONFERENCE CALL DETAILS
| Wednesday, December 18, 2024, 4:20 p.m. Eastern Time | ||
| USA/Canada: | 844-763-8274 | |
| International: | 647-484-8814 | |
| Teleconference Replay dial in: | ||
| USA/Canada: | 855-669-9658 | |
| International: | 412-317-0088 | |
| Replay Passcode: | 5369354 | |
| Webcast/Webcast Replay link - available through January 18, 2026: | ||
| https://www.gowebcasting.com/13876 | ||
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD also operates ATRx Labs, a line of functional mushroom supplements. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.
1 THC-free is defined as below the level of detection using validated scientific analytical tools.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064 email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/234310
FAQ
When will YCBD release its Q4 and FY2024 earnings results?
How can investors access YCBD's Q4 2024 earnings call?
What period will YCBD's upcoming earnings report cover?
How long will YCBD's Q4 2024 earnings call replay be available?
